Skip to main content
. Author manuscript; available in PMC: 2019 May 10.
Published in final edited form as: Eur J Med Chem. 2018 Apr 3;151:450–461. doi: 10.1016/j.ejmech.2018.04.006

Table 4.

Pharmacokinetic parameters of compounds 28 and 35.a

Compounds 28 35
IV
(10 mg/kg)
t1/2b (h) 1.2 0.83
AUC0-tc (ng·h/mL) 14,700 11,400
VSSd (L/kg) 0.864 1.125
CLe (mL/min/kg) 11.5 14.7

PO
(20 mg/kg)
Cmaxf (ng/mL) 80 36
AUC0-t (ng·h/mL) 450 104
a

Compounds were formulated in 10% DMSO/60% PEG-400/30% Saline.

b

half-life.

c

Exposure over test time.

d

Volume of distribution at steady state.

e

Total clearance.

f

Maximum plasma concentration.